Court Snubs Last-Ditch Motion In Univasc Suit

Law360, New York (November 22, 2006, 12:00 AM EST) -- A U.S. district judge has rejected a last-ditch effort by German drug maker Schwarz Pharma AG to avert generic production of its anti-hypertensive drug Univasc by Paddock Laboratories Inc.

Schwarz’s so-called rule 59(e) request to reconsider an earlier ruling was struck down in an order issued Nov. 20 by Judge Ann D. Montgomery in the U.S. District Court for the District of Minnesota.

In the request, Schwarz had argued the court committed manifest errors of law and fact when it granted Paddock's motion for summary judgment...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.